Tufa et al. confirmed our finding concerning lower levels of MDC/CCL22 in patients with COVID-19, as their study highlighted the same tendency [28], and it is noteworthy that they reported negative correlation between MDC/CCL22 and the course of COVID-19. This evidence concerns the gene CCL22 and COVID-19.